Egypt aims to treat 1 million with Hepatitis C in Sudan

Sarah El-Sheikh
2 Min Read

Egypt’s Minister of Health and Population Hala Zayed has met with her Sudanese counterpart Omar Al-Najuib to discuss the Egyptian presidential initiative to treat 1 million people with Hepatitis C in Sudan.

On Tuesday evening, Zayed received Al-Najuib at her ministry’s headquarters to discuss ways of joint cooperation, as part of the depth and interdependence of relations between Egypt and Sudan. The cooperation also aims to build bridges of cooperation between the two countries.

Zayed confirmed that an Egyptian delegation recently completed preparations for five centres in Sudan to work on the initiative, and to train local doctors on diagnostic and treatment protocols. 

The minister also referred to the provision of PCR tests and medical reagents, in addition to providing enough drug doses to treat 250,000 Sudanese citizens.

She affirmed President Abdel Fattah Al-Sisi’s keenness to provide all means of health support to Sudan, in a way that contributes to supporting the health system there. This is based on the joint responsibility between the two countries, and Egypt’s leading role in the African continent.

Khaled Mogahed, spokesperson for Egypt’s Ministry of Health and Population, said ,”The meeting dealt with discussing files of joint cooperation between the two sides, to support the health sector in Sudan in the areas of combating infectious and epidemic diseases, and professional medical education, in addition to settling the pharmaceutical industry in the sister country, and exchanging experiences between the two countries in confronting the novel coronavirus (COVID-19) and providing vaccines.”

He indicated that the meeting also dealt with cooperation between the two countries in the field of medicines.

Mogahed noted that Zayed affirmed her keenness to support the localisation of the pharmaceutical industry in Sudan, especially in the production of vital medicines. 

The two ministers also stressed the importance of exchanging experiences between the two countries in the field of scientific research for epidemic diseases.

Share This Article